Scholars Central

Review articlePublished 2016

Therapeutic Potential of Heme Oxygenase 1 in Ischemia Reperfusion Injury

Authors: Tarik Bozoglu, Rabea Hinkel, Christian Kupatt

Transplantation Technologies & Research

Volume 6 · Issue 3 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Ischemia/reperfusion injury is a reaction occurring after successful treatment of an acute myocardial infarction or in the setting of solid organ transplantation. After successful reperfusion of a previously occluded vessel or a transplanted organ, an additional loss of otherwise vital cells may occur, the so-called lethal ischemia-reperfusion injury. This lethal reperfusion injury is based on rapid tissue oxygenation, leading to a release of reactive oxygen species (ROS) and inducing oxidative stress, endothelial cell activation and inflammation. Experimentally the reperfusion injury can be attenuated via ROS-scavenging, vessel stabilizing and anti-inflammatory interventions. Cytoprotective genes, such as heme oxygenase-1 (HO-1), offer a therapeutic approach to address this problem. Therefore, this review will focus on the beneficial effects of HO-1 in ischemia/reperfusion injury.

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTransplantation Technologies & Research
  • SubjectSurgery
  • BylineArticles whose byline prints “Tarik Bozoglu”
  • BylineArticles whose byline prints “Rabea Hinkel”
  • BylineArticles whose byline prints “Christian Kupatt”